OR WAIT null SECS
March 11, 2025
The company’s 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.
Sterimove will make its North American debut at the April 1–3, 2025 event.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments, in an interview with Pharmaceutical Technology®.
March 10, 2025
The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.
Pharmaceutical Technology® chats with Miguel Forte from ISCT and Kiji Therapeutics about expectations for 2025 and the future technology agenda for industry.
March 08, 2025
Supporting the prosperity of women in science fields benefits the bio/pharmaceutical industry.
Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions.
In an interview with Pharmaceutical Technology®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
March 07, 2025
The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.
The detector features specialized, solid-state dual infrared (IR) sources and dual IR receivers which provide continual cross-checks and internal adjustments to adhere to factory calibration.